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INTRODUCTION {#acr21041-sec-0005}
============

Knee osteoarthritis (OA) affects 14 million US adults and more than 300 million adults worldwide [1](#acr21041-bib-0001){ref-type="ref"}, [2](#acr21041-bib-0002){ref-type="ref"}. The disease is characterized by joint pain, swelling, and stiffness. OA of the lower extremities is associated with diminished quality of life and ranks among the highest contributors to disability globally [3](#acr21041-bib-0003){ref-type="ref"}, [4](#acr21041-bib-0004){ref-type="ref"}, [5](#acr21041-bib-0005){ref-type="ref"}. In the absence of an approved disease‐modifying OA drug, patients with advanced disease frequently turn to total knee replacement (TKR). TKR is an elective surgical procedure that can reduce pain and restore function in persons with knee OA [6](#acr21041-bib-0006){ref-type="ref"}, [7](#acr21041-bib-0007){ref-type="ref"}, [8](#acr21041-bib-0008){ref-type="ref"}. Use of TKR continues to increase rapidly, with more than 660 000 TKRs performed in 2014 in the United States [9](#acr21041-bib-0009){ref-type="ref"}, [10](#acr21041-bib-0010){ref-type="ref"}, [11](#acr21041-bib-0011){ref-type="ref"}.

Although TKR often relieves pain, improves quality of life, and is cost‐effective, evidence suggests that between 10% and 30% of patients undergoing TKR experience suboptimal outcomes, with persistent pain 1 or 2 years after the procedure [12](#acr21041-bib-0012){ref-type="ref"}, [13](#acr21041-bib-0013){ref-type="ref"}, [14](#acr21041-bib-0014){ref-type="ref"}. There is a critical need to understand which patients are at risk for suboptimal TKR outcomes and to determine whether any such risk factors are modifiable. Gandhi et al [15](#acr21041-bib-0015){ref-type="ref"} recently published a study in which they demonstrated that early changes in pain and function over the first 3 months post‐TKR are strongly associated with outcomes at 2 years post‐TKR, suggesting that this early recovery period may be crucial to long‐term outcomes and that any intervention to improve outcomes must occur early. As the authors note, this early recovery period often involves follow‐up appointments with surgeons and physical therapists and may offer a potential opportunity for intervention.

The literature suggests that the improvement patterns over time may be variable, with some patients experiencing rapid improvement and others experiencing a slower and limited improvement [12](#acr21041-bib-0012){ref-type="ref"}, [13](#acr21041-bib-0013){ref-type="ref"}, [14](#acr21041-bib-0014){ref-type="ref"}. Conventional longitudinal models that estimate a mean population trend employ a 1‐size‐fits‐all approach, in which one improvement trend is estimated; covariates can determine how groups may differ from this mean population trajectory, but ultimately, all individuals are assumed to come from the same distribution [16](#acr21041-bib-0016){ref-type="ref"}, [17](#acr21041-bib-0017){ref-type="ref"}. Group‐based trajectory modeling (GBTM) allows for the modeling of separate, distinct subgroups based on longitudinal trajectory and may allow for distinct subgroups in a population to be uncovered.

Although previous work has used this methodology to understand improvement trajectories post‐TKR, the focus of these studies was either on defining long‐term improvement or on the acute post‐TKR recovery period in the days after surgery [18](#acr21041-bib-0018){ref-type="ref"}, [19](#acr21041-bib-0019){ref-type="ref"}, [20](#acr21041-bib-0020){ref-type="ref"}. Understanding recovery patterns and uncovering distinct trajectories in the early months post‐TKR could shed light on which patients may be at risk for suboptimal TKR when intervention is still possible.

In this analysis, we used patient‐reported data from the Adding Value in Knee Arthroplasty (AViKA) Cohort study to describe trajectories of pain and functional improvement over 6 months post‐TKR. We identified preoperative characteristics associated with suboptimal improvement trajectory over 6 months and assessed whether early recovery over 6 months was associated with long‐term patient‐reported outcomes at 24 months, including pain, function, and satisfaction.

PATIENTS AND METHODS {#acr21041-sec-0006}
====================

 {#acr21041-sec-0007}

### Sample {#acr21041-sec-0008}

The AViKA Cohort study was a prospective cohort study of consecutive patients undergoing TKR by five orthopedic surgeons at a tertiary medical center. The surgical approaches or rehabilitation protocols were standardized across these five surgeons' practices. Patients were enrolled between August 2010 and May 2011. Eligible patients were community‐dwelling adults aged 40 years or older, had a primary diagnosis of OA, and spoke English. We excluded patients with a diagnosis other than OA (eg, inflammatory arthritis), those with dementia, those with unicompartmental knee arthroplasty, those who lived in a nursing home, and those with plans for additional elective surgery within 6 months.

### Data elements {#acr21041-sec-0009}

#### Data collection {#acr21041-sec-0010}

All participants completed a baseline questionnaire within 6 weeks prior to surgery and were followed postoperatively at weeks 1, 2.5, 4, 6, and 8 and at months 3, 4, 5, 6, and 24.

#### Outcomes {#acr21041-sec-0011}

Primary outcomes include pain and functional status, which were assessed with the Western Ontario and McMaster Universities Arthritis Index (WOMAC). The WOMAC pain‐ and functional‐status scores were converted to a 0‐100 scale, with 100 being the worst. WOMAC was assessed at each visit with the exception of weeks 1 and 2.5. As a secondary outcome, we assessed overall satisfaction with surgery with the following question: "How satisfied are you with the results of your knee replacement surgery?" Overall satisfaction was classified as very satisfied vs not very satisfied (including somewhat satisfied, somewhat dissatisfied, and very dissatisfied). This stratification was determined by the distribution of responses and the general response to TKR. In this analysis, we sought to describe the short‐term recovery trajectory (over the first 6 months post‐TKR) and the association between short‐term recovery trajectory and long‐term outcomes at 24 months post‐TKR.

#### Covariates {#acr21041-sec-0012}

We assessed demographics and preoperative clinical characteristics of the cohort at baseline, including age, race, sex, body mass index (BMI), Charlson Comorbidity Index [21](#acr21041-bib-0021){ref-type="ref"}, preoperative medication use for knee pain, five‐item Mental Health Index (MHI‐5) [22](#acr21041-bib-0022){ref-type="ref"}, Pain Catastrophizing Scale (PCS) [23](#acr21041-bib-0023){ref-type="ref"}, use of assisted devices, and the Musculoskeletal (MSK) Functional Limitations Index [24](#acr21041-bib-0024){ref-type="ref"}. BMI was calculated from self‐reported height and weight. We then stratified BMI into four groups: BMI less than or equal to 25.0, BMI of 25.1‐30.0, BMI of 30.1‐35.0, and BMI greater than 35.0. The Charlson Comorbidity Index was grouped into none, 1, 2, and 3 or more. Medication use was categorized into three groups: none, occasional, and almost daily. The MHI‐5 was scaled from 0 to 100, with 100 being the best, and was dichotomized as less than 68 and greater than or equal to 68 [25](#acr21041-bib-0025){ref-type="ref"}. PCS measured catastrophic thinking related to pain and was scaled from 0 to 52, with 52 being the worst. The MSK Functional Limitation Index aggregated self‐reported MSK problems in six anatomic regions that limit patients' ability to perform daily activities and was scaled from 0 to 12, with 12 being the worst.

### Statistical analysis {#acr21041-sec-0013}

#### Descriptive statistics {#acr21041-sec-0014}

We first conducted descriptive analysis to describe short‐term improvement after TKR. We assessed pain and function at each time point from baseline through 6 months using mean and SD.

#### Group‐based trajectory modeling {#acr21041-sec-0015}

We used GBTM to determine whether there were latent classes (trajectory groups) with different patterns of pain and function over time [17](#acr21041-bib-0017){ref-type="ref"}, [26](#acr21041-bib-0026){ref-type="ref"}, [27](#acr21041-bib-0027){ref-type="ref"}. We determined trajectory groups separately for WOMAC pain and function, which were assessed at predefined time intervals from baseline to 6 months. The GBTM approach uses pain and function at each time point and uses multinomial modeling to identify multiple trajectory groups. Although conventional longitudinal modeling estimates a mean population trend, GBTM allows for the possibility that there are distinct subgroups within a population. We used a censored normal model, which allows for clustering at the minimum and maximum of scales. This is useful for scales with prespecified ranges, (eg, WOMAC). We considered between one and four trajectories and allowed for up to a fourth‐order polynomial in each trajectory group.

We used the Bayesian information criterion (BIC) as an indicator for the selection of the optimal model. Higher BIC values indicate better model fit. However, BIC values do not always clearly identify the optimal number of groups in GBTM. Therefore, we also took into account group size and stability during the model selection. We selected models with at least 10 participants (approximately 10% of sample) in each group and with similar trajectory shapes when we adjusted the order of polynomial. We then used posterior group‐membership probabilities as indicators of model fit. At the individual level, a subject is assigned a posterior group‐membership probability for each trajectory group, measuring the likelihood of belonging to that specific trajectory, with the probabilities summing to 1 across all groups. Probabilities close to 1 indicate more certainty about trajectory‐group membership; Nagin [17](#acr21041-bib-0017){ref-type="ref"} suggests that an average posterior probability in each trajectory group greater than or equal to 0.7 indicates moderate to excellent model fit.

#### Association between preoperative characteristics and trajectories {#acr21041-sec-0016}

After determining the number of trajectories and group membership, we evaluated the bivariate association between preoperative cohort characteristics and trajectory‐group membership using the *t* test for continuous variables and the χ^2^ test for categorical variables. We included variables shown to be statistically significant (*P* \< 0.05) in a bivariate analysis in a multivariable logistic regression model.

#### Association between 24‐month outcomes and early improvement trajectories {#acr21041-sec-0017}

We examined the associations between early improvement trajectory over 6‐ and 24‐month outcomes, including pain, function, and satisfaction. We used short‐term (first 6 months post‐TKR) trajectory‐group membership as the main exposure. We conducted separate analyses for each of these outcomes. First, we used the Wilcoxon rank sum test to compare 24‐month pain and function outcomes between the different trajectories (optimal vs suboptimal). Then we used generalized linear models to evaluate the association between 24‐month pain and function outcomes and early improvement trajectory, adjusting for preoperative covariates described previously that had significant bivariate associations with pain or function trajectory groups. For 24‐month satisfaction, we assessed its association with trajectory‐group membership using the χ^2^ test or Fisher\'s exact test. We built multivariate logistic regression to determine the independent factors associated with outcomes, adjusting for significant covariates described previously.

#### Sensitivity analysis for missing data {#acr21041-sec-0018}

We assessed whether cohort characteristics differed between study completers vs noncompleters and compared the dropout rate between trajectory groups. We then used multiple imputation (MI) to augment missing 24‐month pain and function outcome data. MI uses a prediction equation to impute missing values, incorporating information about observed data [28](#acr21041-bib-0028){ref-type="ref"}. We accounted for factors that were different between study completers vs noncompleters in addition to observed pain and function. We reran the generalized linear models for the 24‐month pain and function outcomes, incorporating the imputed outcomes. To more accurately reflect the uncertainty in missing values, we created five imputed data sets and then used the MIANALYZE procedure in SAS (SAS Institute, Inc) to combine the results across the five imputations.

Data were collected and managed using Research Electronic Data Capture (REDCap), which is hosted by the Partners HealthCare, Research Computing, Enterprise Research Infrastructure & Services (ERIS) group [29](#acr21041-bib-0029){ref-type="ref"}. All analyses were conducted in SAS version 9.4 (SAS Institute, Inc). We used SAS PROC TRAJ, a custom SAS procedure available for free download, for GBTM analyses [26](#acr21041-bib-0026){ref-type="ref"}, [27](#acr21041-bib-0027){ref-type="ref"}.

RESULTS {#acr21041-sec-0019}
=======

 {#acr21041-sec-0020}

### Sample description {#acr21041-sec-0021}

A total of 185 participants were eligible for the study; 132 (71%) agreed to participate, and of these, 116 (88%) completed a baseline visit. A total of 110 patients underwent TKR; 3 patients had bilateral TKR and were excluded, leaving an analytic cohort of 107 participants. The 78 patients eligible and not included in the analytic cohort were slightly older than the 107 patients included (65.6 vs 64.7 years) and were more likely to be women (51% vs 61%). The demographic difference did not reach statistical differences (*P* = 0.53 for age; *P* = 0.21 for sex).

The average age was 64.7 years (SD 8.8), 51% were women, and 88% were white (Table [1](#acr21041-tbl-0001){ref-type="table"}). The average BMI was 31.2 (SD 6.6). There were 21 (20%) participants with a BMI less than 25, 31 (29%) participants had a BMI of 25‐29.9, 31 (29%) had a BMI of 30‐34.9, and 23 (22%) had a BMI greater than or equal to 35. The mean Charlson Comorbidity Index score was 1.4 (SD 1.8), and 21 (20%) participants had a score higher than 2. Forty‐three percent reported taking medication for knee pain almost every day. The average PCS score was 12.2 (SD 11.3). There were 25 (23%) participants with an MHI‐5 less than 68. The overall mean MSK index score was 3.5 (SD 2.1). Thirty‐two percent reported use of a supportive device in the last week.

###### 

Cohort characteristics

  Cohort Characteristics                                                                  Overall (N = 107)
  --------------------------------------------------------------------------------------- -------------------
  WOMAC function score, mean (SD)[a](#acr21041-note-0007){ref-type="fn"}                  43.68 (14.92)
  WOMAC pain score, mean (SD)[a](#acr21041-note-0007){ref-type="fn"}                      42.45 (17.43)
  Index of MSK functional limitations, mean (SD)[b](#acr21041-note-0008){ref-type="fn"}   3.52 (2.10)
  Use of any supportive device in the past week, n (%)                                     
  No                                                                                      73 (68.2)
  Yes                                                                                     34 (31.8)
  Age at surgery, mean (SD), y                                                            64.72 (8.84)
  Race/ethnicity, n (%)                                                                    
  Multiracial: Black, Hispanic, mixed‐race                                                13 (12.1)
  White                                                                                   94 (87.9)
  Sex, n (%)                                                                               
  Male                                                                                    52 (48.6)
  Female                                                                                  55 (51.4)
  BMI group, n (%)                                                                         
  \<25                                                                                    21 (19.8)
  ≤25‐30                                                                                  31 (29.2)
  ≤30‐35                                                                                  31 (29.3)
  ≥35                                                                                     23 (21.7)
  Charlson Comorbidity Index group, n (%)                                                  
  0                                                                                       43 (40.6)
  1                                                                                       22 (20.7)
  2                                                                                       20 (18.9)
  3+                                                                                      21 (19.8)
  Pain medication use for knee, n (%)                                                      
  No                                                                                      25 (23.4)
  Yes, occasionally                                                                       36 (33.6)
  Yes, almost every day                                                                   46 (43.0)
  Pain Catastrophizing Scale, mean (SD)[c](#acr21041-note-0009){ref-type="fn"}            12.22 (11.34)
  MHI‐5 category: \<68 vs ≥68, n (%)[d](#acr21041-note-0010){ref-type="fn"}                
  \<68                                                                                    25 (23.4)
  ≥68                                                                                     82 (76.6)

Abbreviation: BMI, body mass index; MHI‐5, five‐item Mental Health Index; MSK, musculoskeletal; WOMAC, Western Ontario and McMaster Universities Arthritis Index.

Scaled at 0‐100, with 100 being the worst.

Scaled at 0‐12, with 12 being the worst.

Scaled at 0‐52, with 52 being the worst.

Scaled at 0‐100, with 100 being the best; the cutoff is at 68.

John Wiley & Sons, Ltd

### Longitudinal WOMAC pain and function at 6 months {#acr21041-sec-0022}

The average preoperative WOMAC pain and function scores were 42.5 (SD 17.4) and 43.7 (SD 14.9), respectively. Both improved substantially in the 6 months post‐TKR, with 6‐month pain and function scores of 9.7 (SD 11.8) and 11.5 (SD 12.8), respectively (Appendix Figures [1](#acr21041-app-0001){ref-type="app"} and [2](#acr21041-app-0001){ref-type="app"}).

### Group‐based trajectory modeling {#acr21041-sec-0023}

#### Pain {#acr21041-sec-0024}

We identified two distinct early pain‐improvement trajectories (Figure [1](#acr21041-fig-0001){ref-type="fig"}): 67 (63%) participants in group 1 (optimal improvement) improved from a mean preoperative pain score of 39.3 (SD 16.3) to a mean score of 3.8 (SD 5.7) at 6 months, and 40 (37%) participants in group 2 (suboptimal improvement) had higher preoperative pain (mean 47.8 \[SD 18.2\]) and a higher 6‐month score (mean 19.2 \[SD 13.0\]). The average posterior group‐membership probability was 0.93 for group 1 and 0.92 for group 2, indicating good model fit.

![Group‐based early improvement trajectories for the Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain score. The WOMAC pain score is along the y‐axis, and follow‐up week is along the x‐axis. The short dashed lines depict the mean WOMAC pain score over 6 months post surgery. The solid lines depict the predicted trajectory, and the medium dashed lines represent 95% confidence intervals.](ACR2-1-308-g001){#acr21041-fig-0001}

Fifty percent of participants who reported use of a supportive device at baseline were in the suboptimal pain trajectory group, compared with 32% of those who did not require a supportive device (*P* = 0.066). Patients in the suboptimal pain trajectory group had a higher PCS compared with the optimal pain trajectory group (14.8 vs 10.7; *P* = 0.072). The MHI‐5 was significantly associated with the pain‐improvement trajectory group: 56% of patients who reported an MHI‐5 less than 68 were in the suboptimal pain trajectory group, compared with 32% of those with an MHI‐5 greater than or equal to 68 (*P* = 0.028) (Table [2](#acr21041-tbl-0002){ref-type="table"}). Associations were similar in the multivariable model, with higher pain catastrophizing, a lower MHI‐5, and use of a supportive device associated with increased odds of being in the suboptimal pain trajectory, although none of the covariates reached statistical significance.

###### 

Associations between patient characteristics and early improvement trajectory

  Cohort Characteristics                                                                  WOMAC Pain    WOMAC Function                                      
  --------------------------------------------------------------------------------------- ------------- ---------------- ------- ------------ ------------- ---------
  Age group, y, n (%)                                                                                                    0.705                              0.578
  \<65                                                                                    36 (61.0)     23 (39.0)        ...     35 (59.3)    24 (40.7)     ...
  65+                                                                                     31 (64.6)     17 (35.4)        ...     31 (64.6)    17 (35.4)     ...
  Sex, n (%)                                                                                                             0.823                              0.976
  Male                                                                                    32 (61.5)     20 (38.5)        ...     32 (61.5)    20 (38.5)     ...
  Female                                                                                  35 (63.6)     20 (36.4)        ...     34 (61.8)    21 (38.2)     ...
  Race/ethnicity, n (%)                                                                                                  0.191                              0\. 535
  Multiracial: Black, Hispanic, mixed race                                                6 (46.2)      7 (53.8)         ...     7 (53.8)     6 (46.2)      ...
  White                                                                                   61 (64.9)     33 (35.1)        ...     59 (62.8)    35 (37.2)     ...
  BMI group, n (%)                                                                                                       0.403                              0.465
  \<25                                                                                    15 (71.4)     6 (28.6)         ...     14 (66.7)    7 (33.3)      ...
  ≤25‐30                                                                                  20 (64.5)     11 (35.5)        ...     19 (61.3)    12 (38.7)     ...
  ≤30‐35                                                                                  20 (64.5)     11 (35.5)        ...     21 (67.7)    10 (32.3)     ...
  ≥35                                                                                     11 (47.8)     12 (52.2)        ...     11 (47.8)    12 (52.2)     ...
  Charlson Comorbidity Index group, n (%)                                                                                0.181                              0.736
  0                                                                                       31 (72.1)     12 (27.9)        ...     27 (62.8)    16 (37.2)     ...
  1                                                                                       15 (68.2)     7 (31.8)         ...     15 (68.2)    7 (31.8)      ...
  2                                                                                       9 (45.0)      11 (55.0)        ...     13 (65.0)    7 (35.0)      ...
  3+                                                                                      12 (57.1)     9 (42.9)         ...     11 (52.4)    10 (47.6)     ...
  Pain Catastrophizing Scale, mean (SD)[b](#acr21041-note-0014){ref-type="fn"}            10.7 (10.0)   14.8 (13.0)      0.072   9.7 (10.4)   16.2 (11.8)   0.003
  Index of MSK functional limitations, mean (SD)[c](#acr21041-note-0016){ref-type="fn"}   3.4 (2.0)     3.7 (2.2)        0.566   3.3 (1.9)    4.0 (2.4)     0.097
  MHI‐5 category: \<68 vs ≥68, n (%)                                                                                     0.028                              0.003
  \<68                                                                                    11 (44.0)     14 (56.0)        ...     9 (36.0)     16 (64.0)     ...
  ≥68                                                                                     56 (68.3)     26 (31.7)        ...     57 (69.5)    25 (30.5)     ...
  Use of any supportive device in the past week, n (%)                                                                   0.066                              0.001
  No                                                                                      50 (68.5)     23 (31.5)        ...     53 (72.6)    20 (27.4)     ...
  Yes                                                                                     17 (50.0)     17 (50.0)        ...     13 (38.2)    21 (61.8)     ...

Abbreviation: BMI, body mass index; MHI‐5, five‐item Mental Health Index; MSK, musculoskeletal; WOMAC, Western Ontario and McMaster Universities Arthritis Index.

*t* tests were performed for continuous variables; χ^2^ tests were performed for categorical variables.

Mean (SD) is presented for continuous variables; n (%) is presented for categorical variables.

Scaled at 0‐52, with 52 being the worst.

Scaled at 0‐12, with 12 being the worst.

John Wiley & Sons, Ltd

#### Function {#acr21041-sec-0025}

We identified two distinct early function‐improvement trajectories (Figure [2](#acr21041-fig-0002){ref-type="fig"}): 66 (62%) participants in group 1 (optimal) improved from a mean pre‐TKR score of 39.2 (SD 14.4) to a score of 5.3 (SD 6.0) at month 6; 41 (38%) participants in the suboptimal functional‐improvement trajectory group changed from a pre‐TKR score of 50.9 (SD 12.9) to a score of 23.5 (SD 14.1) at 6 months post‐TKR. The average posterior group‐membership probability was 0.973 for group 1 and 0.937 for group 2, indicating good model fit.

![Group‐based early improvement trajectories for the Western Ontario and McMaster Universities Arthritis Index (WOMAC) function score. WOMAC function score is along the y‐axis, and follow‐up week is along the x‐axis. The short dashed lines depict the mean WOMAC function score over 6 months post surgery. The solid lines depict the predicted trajectory, and the medium dashed lines represent 95% confidence intervals.](ACR2-1-308-g002){#acr21041-fig-0002}

The PCS, the MHI‐5, and pre‐TKR supportive device use were significantly associated with function‐improvement trajectory. Sixty‐two percent of participants who reported use of a supportive device at baseline were in the suboptimal function‐improvement trajectory group, compared with 27% of those who reported not using a supportive device (*P* = 0.001). Patients in the suboptimal function‐improvement trajectory group had a higher PCS compared with those in the optimal function‐improvement trajectory group (16.2 vs 9.7; *P* = 0.003). Sixty‐four percent of patients who reported an MHI‐5 less than 68 were in the suboptimal function‐improvement trajectory group, compared with 31% of those with an MHI‐5 greater than or equal to 68 (*P* = 0.003) (Table [2](#acr21041-tbl-0002){ref-type="table"}). The MHI‐5 and use of supportive device remained significantly associated with function‐improvement trajectory in the multivariable logistic regression. The adjusted odds ratio of being in the suboptimal functional trajectory for users of pre‐TKR supportive device compared with nonusers was 4.0 (95% confidence interval \[CI\]: 1.5‐10.2), whereas the adjusted odds ratio for those with an MHI‐5 less than 68 compared with an MHI‐5 greater than or equal to 68 was 3.8 (95% CI: 1.3‐11.8). The PCS was not found to be significantly associated with function‐improvement trajectory (adjusted odds ratio 1.0; 95% CI: 1.0‐1.1).

#### Pain and function {#acr21041-sec-0026}

Fifty‐six (52%) participants were in both the optimal pain‐improvement trajectory and the optimal functional‐improvement trajectory, whereas 30 (28%) participants were in suboptimal trajectories for both pain and functional status. Ten participants (9%) were in the suboptimal pain‐improvement trajectory but the optimal functional‐improvement trajectory, and 11 (10%) participants were in the optimal pain‐improvement trajectory but the suboptimal functional‐improvement trajectory.

### Twenty‐four--month outcomes {#acr21041-sec-0027}

At 24 months post‐TKR, the mean WOMAC pain and function scores were 5.8 (SD 11.9) and 7.9 (SD 12.8), respectively. The mean twenty‐four--month pain score was 11.7 (SE 3.6) in the early suboptimal pain trajectory and 3.1 (SE 0.9) in the early optimal pain trajectory (*P* = 0.005) (Table [3](#acr21041-tbl-0003){ref-type="table"}). After adjusting for the PCS, the MHI‐5, and use of a supportive device, the difference in pain scores between the two early pain‐improvement trajectories remained statistically significant (11.6 vs 4.0; *P* = 0.004). We observed similar results for function: after adjusting for the PCS, the MHI‐5, and use of a supportive device, 24‐month function scores differed between 6‐month suboptimal and optimal trajectories (15.1 vs 5.6; *P* = 0.001).

###### 

Associations between 24‐month outcomes and 6‐month improvement trajectories

  Analyses                                 24‐mo WOMAC Pain   24‐mo WOMAC Function                                               
  ---------------------------------------- ------------------ ---------------------- ------- ---------------- ------------------ -------
  Unadjusted analysis, mean (SE), median   3.1 (0.9), 0       11.7(3.6), 5           0.005   3.7 (1.0), 0.7   16.9 (3.4), 13.2   0.000
  Adjusted analysis, mean (SE)             4.0 (1.5)          11.6 (2.1)             0.004   5.6 (1.5)        15.1 (2.1)         0.001
  Adjusted analysis after MI, mean (SE)    8.0(3.0)           14.2 (3.2)             0.033   10.9 (2.2)       17.9 (2.1)         0.008

Abbreviation: MI, multiple imputation.

John Wiley & Sons, Ltd

### Satisfaction and early improvement trajectory group {#acr21041-sec-0028}

Seventy‐one percent of the study participants reported that they were very satisfied with surgery at 6 months, and 82% reported that they were very satisfied at 24 months. Ninety percent of the participants in the early optimal pain trajectory group were very satisfied at 24 months, compared with 64% in the early suboptimal pain trajectory group (*P* = 0.010). After adjusting for the PCS, the MHI‐5, and use of a supportive device, satisfaction remained significantly associated with the pain trajectory group, with participants in the early optimal pain trajectory group having 5.2 times the odds (95% CI: 1.4‐18.9) of being very satisfied with surgery at 24 months, compared with those in the early suboptimal pain trajectory group (Table [4](#acr21041-tbl-0004){ref-type="table"}). We found a similar pattern for 24‐month satisfaction in the early function trajectory group.

###### 

Associations between 24‐month satisfaction and 6‐month improvement trajectories

  Analyses                                           24‐mo Satisfaction                                                                                          
  -------------------------------------------------- -------------------- ----------- ---------------- ---------------- ----------- ----------- ---------------- ----------------
  Very satisfied                                     47 (74.6)            16 (25.4)   5.3 (1.5‐18.1)   5.2 (1.4‐18.9)   48 (76.2)   15 (23.8)   8.0 (2.2‐29.2)   8.0 (2.0‐32.4)
  Somewhat satisfied/somewhat or very dissatisfied   5 (35.7)             9 (64.3)    ...              ...              4 (28.6)    10 (71.4)   ...              ...

Abbreviation: CI, confidence interval; OR, odds ratio.

John Wiley & Sons, Ltd

### Impact of missing data {#acr21041-sec-0029}

Of 107 participants, 99 (93%) completed the 6‐month visit, and 79 (74%) completed the 24‐month visit. Among the 28 participants who dropped out of the study before 24 months, 15 (54%) participants were lost to follow‐up, 5 (18%) had surgery on the contralateral knee and were discontinued, 2 (7%) died, and 6 (21%) dropped out because of other reasons. There were more dropouts in the early suboptimal pain‐ and function‐improvement groups: 15 (38%) participants in the suboptimal pain trajectory group dropped out before 24 months, compared with 13 (19%) participants in the optimal pain trajectory group. Sixteen (39%) participants in the suboptimal function trajectory group dropped out before 24 months, compared with 12 (18%) participants in the optimal function trajectory group. Compared with participants who did not complete the 24‐month visit, study completers tended to have a lower preoperative PCS (mean 10.5 for completers vs 17.2 for dropouts), a higher proportion had MHI‐5 scores greater than or equal to 68 (82% for completers vs 61% for dropouts), and a lower proportion used supportive device (28% for completers vs 43% for dropouts) preoperatively.

We accounted for observed pain and function, demographics (age, sex, and race), and potential factors for dropout (mental health and use of supportive device) in the MI. After MI, differences in 24‐month outcome between trajectory groups were slightly attenuated (Table [3](#acr21041-tbl-0003){ref-type="table"}). The adjusted mean 24‐month pain score was 8.0 (SE 3.0) for the early optimal pain trajectory group compared with 14.2 (SE 3.2) for the suboptimal pain trajectory group (*P* = 0.033). The adjusted mean 24‐month function score was 10.9 (SE 2.2) for the optimal functional‐improvement trajectory group compared with 17.9 (SE 2.1) for the suboptimal functional‐improvement trajectory group (*P* = 0.008).

DISCUSSION {#acr21041-sec-0030}
==========

We identified two distinct trajectories of pain and function recovery in the first 6 months following TKR. We found that accelerated improvement over the first 6 months is predictive of optimized pain relief, functional status, and satisfaction with TKR at 24 months after surgery. For both pain and function, approximately one‐third of participants were in the early suboptimal improvement trajectories. Higher pain catastrophizing, worse mental health status, and use of a supportive device prior to TKR were associated with being in a suboptimal improvement trajectory.

Several studies have investigated recovery trajectories following joint replacement surgery. For instance, Page et al [19](#acr21041-bib-0019){ref-type="ref"} examined WOMAC pain trajectories over the first year following TKR using growth‐mixture modeling. The authors identified four trajectories, with three trajectories exhibiting marked pain improvement and one trajectory (9% of the cohort) demonstrating persistently high pain levels. Poorer preoperative lower‐extremity functioning, higher anxiety scores, and higher levels of functioning difficulty were associated with being in the persistent pain group. Similarly, Dowsey et al [18](#acr21041-bib-0018){ref-type="ref"} used latent class growth analysis to classify groups of subjects according to their trajectory of knee pain and function over 1‐5 years post‐TKR using the Knee Society Score. The authors identified three pain trajectories based on the profile of the Knee Society Score over the 5‐year period, which they named "no pain" (33%), "mild pain" (45%), and "moderate pain" (22%). The authors found that the preoperative 12‐Item Short Form Health Survey (SF‐12) mental component summary and physical component summary and a higher Charlson Comorbidity Index were associated with being in a worse recovery trajectory.

Across the studies by Page et al [19](#acr21041-bib-0019){ref-type="ref"} and Dowsey et al [18](#acr21041-bib-0018){ref-type="ref"} and our study, distinct pain and function recovery trajectories have been consistently identified despite the postoperative time frame considered. In addition, the studies by Page et al [19](#acr21041-bib-0019){ref-type="ref"} and Dowsey et al [18](#acr21041-bib-0018){ref-type="ref"} and our study found that poorer baseline physical and mental function were associated with a worse recovery trajectory. The association between baseline levels of pain and functional status and 6‐ and 24‐month pain and function has been demonstrated previously [30](#acr21041-bib-0030){ref-type="ref"}, [31](#acr21041-bib-0031){ref-type="ref"}.

Another study used short‐term WOMAC scores over 3 to 12 months to predict long‐term outcomes at 24 months [15](#acr21041-bib-0015){ref-type="ref"}. The study found that 80.3% and 79.9% of changes in pain and function, respectively, over the 2 years occurred within the first 3 months. Early changes were associated with final outcomes: changes in pain and function from baseline to 3 months post‐TKR explained the greatest proportion of variability of pain and function at 2 years (16% for pain; 23% for function). A higher comorbidity count and a worse presurgery score were found to be significantly associated with worse 2‐year pain and function scores. These results were consistent with results of our analyses that showed strong association between early pain and function trajectories and outcome at 2 years.

A major strength of our study is the frequent and standardized data collection during the early postoperative period, with WOMAC scores assessed at seven time points between week 4 and month 6. This may have enhanced our ability to separate trajectory from pain flare. We also know that the recovery trend over time for TKR is nonlinear [15](#acr21041-bib-0015){ref-type="ref"}, [32](#acr21041-bib-0032){ref-type="ref"}; these multiple time points allowed us to model the early rapid recovery over months 0‐3 and the later slower recovery over months 3‐6.

Our analysis had several limitations. Decisions regarding the number and shape of trajectories are somewhat subjective [17](#acr21041-bib-0017){ref-type="ref"}. We used BIC and posterior group‐membership probabilities to guide our decisions and sought stable groups with at least 10% of the cohort (approximately 10 participants). It is possible that our modest sample size of 107 limited our ability to uncover a small persistently high pain trajectory or a high disability trajectory, as seen, for example, in the work by Page et al [19](#acr21041-bib-0019){ref-type="ref"}. Another possible limitation is biased losses to follow‐up. Our study had 93% completion at the month 6 visit; thus, we do not think that potential missing not at random data would greatly impact our observed trajectories. However, we did note important differences in follow‐up at 24 months, with more dropouts in the high pain‐ and functional‐impairment groups and important differences in the PCS, the MHI‐5, and functional impairment between the study completers vs dropouts. To assess the impact of this dropout on our 24‐month outcome analysis, we used an MI approach and found that the differences in 24‐month pain and function between short‐term trajectory groups were attenuated in this analysis. These data come from one academic medical center in the Northeast United States and may not be generalizable to other TKR populations.

Our cohort represented 58% of eligible patients receiving TKR, and we found differences in age and sex between those who agreed to participate and were included in the analysis vs those who refused and/or were excluded. In addition, although we did not find an association between preoperative medication use and recovery trajectories, we did not have data on specific medication use. Although we also believe postsurgery complications, including infection and implant, are highly correlated with pain, we do not have data on them. Lastly, individual pain thresholds would be an informative covariate in identifying recovery trajectories, but we did not ascertain this information in the current study sample.

We identified two distinct pain recovery trajectories and two distinct function recovery trajectories in the 6 months following TKR. Pain or function trajectories diverged as early as 6‐8 weeks post‐TKR. These early recovery trajectories were associated with differential outcome at 2 years, with those patients in the slower recovery trajectories having higher pain, higher functional limitations, and less satisfaction compared with those patients in the faster recovery trajectories. This early recovery period in the first months after TKR may represent a window for intervention aimed at improvement of TKR outcomes.
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**Appendix Figure 1.** Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain over time. WOMAC pain is along the y‐axis and week post surgery is along the x‐axis. Week 0 represents the preoperative questionnaire. Boxplots display the raw data at each time point: the diamond is the mean; the box corresponds to the 25th percentile (lowest line), the 50th percentile (middle line), and the 75th percentile (top line), with whiskers extended to the most extreme observations that are not outliers. Outliers are represented by circles.

**Appendix Figure 2.** Western Ontario and McMaster Universities Arthritis Index (WOMAC) function over time. WOMAC function is along the y‐axis, and week post surgery is along the x‐axis. Week 0 represents the preoperative questionnaire. Boxplots display the raw data at each time point: the diamond is the mean; the box corresponds to the 25th percentile (lowest line), the 50th percentile (middle line), and the 75th percentile (top line), with whiskers extended to the most extreme observations that are not outliers. Outliers are represented by circles.
